Evidence map›Paper›PMID 32571957›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Vitamin B12 and folic acid alleviate symptoms of nutritional deficiency by antagonizing aryl hydrocarbon receptor.

Daniel J Kim, Arvind Venkataraman, Priyanka Caroline Jain, Eleanor P Wiesler, Melody DeBlasio, Jonathan Klein, Stephanie S Tu, Seohyuk Lee, Ruslan Medzhitov, Akiko Iwasaki

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Structural biology of SARS-CoV-2: open the door for novel therapies.Signal transduction and targeted therapy · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Daniel J KimDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0003-4351-8224
Arvind VenkataramanDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Priyanka Caroline JainDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Eleanor P WieslerDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0002-0760-390X
Melody DeBlasioDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Jonathan KleinDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Stephanie S TuDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0002-4452-5189
Seohyuk LeeDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Ruslan MedzhitovDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0002-7021-2012
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520; akiko.iwasaki@yale.edu.ORCID 0000-0002-7824-9856
Yale University · USHoward Hughes Medical Institute · US

Funding

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH75N93019C00051 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAMMER, FLORIAN · 2019 to 2025
$105.4M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
Role of viral infections in potassium channel-related cerebellar ataxiaR01NS111242 · NINDS · YALE UNIVERSITY · PI IWASAKI, AKIKO, KACZMAREK, LEONARD K · 2019 to 2023
$2.7M
Short Term Research Training: Students in Health Professional SchoolsT35DK104689 · NIDDK · YALE UNIVERSITY · PI LLOYD G CANTLEY, Sarwat I Chaudhry · 2015 to 2026
$2.6M
B cell based protection against recurrent herpesR01AI127429 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2017 to 2021
$2.1M
Exploring the Innate Sensors Underlying Cancer ImmunosurveillanceF30CA236466 · NCI · YALE UNIVERSITY · PI KIM, DANIEL J · 2019 to 2021
$111k
Howard Hughes Medical InstituteNCI NIH HHS F30 CA236466NIAID NIH HHS 75N93019C00051NIAID NIH HHS R01 AI127429NIAID NIH HHS U19 AI089992NIDDK NIH HHS T35 DK104689NIGMS NIH HHS T32 GM007205NIGMS NIH HHS T32 GM136651NINDS NIH HHS R01 NS111242
6 · The paper itself

Abstract

Despite broad appreciation of their clinical utility, it has been unclear how vitamin B12 and folic acid (FA) function at the molecular level to directly prevent their hallmark symptoms of deficiency like anemia or birth defects. To this point, B12 and FA have largely been studied as cofactors for enzymes in the one-carbon (1C) cycle in facilitating the de novo generation of nucleotides and methylation of DNA and protein. Here, we report that B12 and FA function as natural antagonists of aryl hydrocarbon receptor (AhR). Our studies indicate that B12 and FA bind AhR directly as competitive antagonists, blocking AhR nuclear localization, XRE binding, and target gene induction mediated by AhR agonists like 2,3,7,8-tetrachlorodibenzodioxin (TCDD) and 6-formylindolo[3,2-b]carbazole (FICZ). In mice, TCDD treatment replicated many of the hallmark symptoms of B12/FA deficiency and cotreatment with aryl hydrocarbon portions of B12/FA rescued mice from these toxic effects. Moreover, we found that B12/FA deficiency in mice induces AhR transcriptional activity and accumulation of erythroid progenitors and that it may do so in an AhR-dependent fashion. Consistent with these results, we observed that human cancer samples with deficient B12/FA uptake demonstrated higher transcription of AhR target genes and lower transcription of pathways implicated in birth defects. In contrast, there was no significant difference observed between samples with mutated and intact 1C cycle proteins. Thus, we propose a model in which B12 and FA blunt the effect of natural AhR agonists at baseline to prevent the symptoms that arise with AhR overactivation.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCarbazolesCongenital AbnormalitiesFemaleFolic AcidFolic Acid DeficiencyGene ExpressionHumansMaleMalnutritionMiceMice, Inbred C57BLNeoplasmsPolychlorinated DibenzodioxinsReceptors, Aryl Hydrocarbon6-formylindolo(3,2-b)carbazoleAhr protein, mouseBasic Helix-Loop-Helix ProteinsCarbazolesFolic AcidPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonVitamin B 12AhRbirth defectfolic acidnutritionvitamin

Identifiers

PMID32571957
PMCPMC7355044
OpenAlexW3038126706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.